Search

Your search keyword '"Lai, Chi‐Chun"' showing total 1,029 results

Search Constraints

Start Over You searched for: Author "Lai, Chi‐Chun" Remove constraint Author: "Lai, Chi‐Chun"
1,029 results on '"Lai, Chi‐Chun"'

Search Results

1. A Multimodal Imaging–Based Deep Learning Model for Detecting Treatment-Requiring Retinal Vascular Diseases: Model Development and Validation Study

2. Deep Learning–Based Detection of Early Renal Function Impairment Using Retinal Fundus Images: Model Development and Validation

5. Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS)

11. Systemic effects of anti-VEGF intravitreal injection in patients with age-related macular degeneration: A multi-institutional real-world study

12. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

14. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

19. Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study

25. Polypoidal Choroidal Vasculopathy: Updates on Risk Factors, Diagnosis, and Treatments

30. A hospital cluster of COVID-19 associated with a SARS-CoV-2 superspreading event

31. Evaluating the effect of 0.125% atropine on foveal microvasculature using optical coherence tomography angiography.

32. Optical Coherence Tomography Classification Systems for Diabetic Macular Edema and Their Associations With Visual Outcome and Treatment Responses – An Updated Review

35. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

36. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

47. Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society

50. Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy

Catalog

Books, media, physical & digital resources